ChartRow logo
Data provided bySource: Twelve Data
HALO
$95.97-0.55%
as of close, Nov 17, 2026
☾ AH $95.97 -0.55%
Share this page

HALO financial statements

The full income statement, balance sheet, and cash-flow statement for Halozyme Therapeutics Inc. (HALO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +39.2%10Y CAGR +26.3%YoY +39.2%
$1.8B TTM$493M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +39.1%10Y CAGR +27.1%YoY +37.3%
$1.5B TTM$410.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +26.6%10Y n/mYoY +35.4%
$674.2M TTM$295M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +19.7%10Y n/mYoY +41.0%
$485.4M TTM$247M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +23.0%10Y n/mYoY +40.6%
$3.97 TTM$2.01 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +63.7%10Y n/mYoY +44.6%
$898.3M TTM$258.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +22.7%10Y CAGR +11.4%YoY +0.7%
$12.4M TTM$3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +64.8%10Y n/mYoY +45.4%
$885.9M TTM$255.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −12.4%10Y −2.2%YoY +0.2%
122.2M TTM122.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every HALO chart on Trends →

Shares outstanding (point-in-time)

2024-09 127.2M2024-12 123.2M2025-03 123.2M2025-06 117.0M2025-09 117.6M2025-12 118.0M2026-03 118.6M2026-06 113.5M2026-09 114.0M-10.4% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue1.40B+37.6%1.02B+22.4%829M+25.6%660M+48.9%443M+65.7%
1.17B+36.4%856M+34.4%637M+22.3%521M+43.9%362M+61.4%
Cost of revenue229M+43.5%159M-17.1%192M+38.1%139M+71.1%81.4M+87.7%
Research & development81.5M+3.1%79.0M+3.5%76.4M+14.6%66.6M+86.7%35.7M+4.2%
Selling, general & administrative207M+34.2%154M+3.5%149M+3.9%144M+185.2%50.3M+10.0%
Amortization of intangibles76.7M+7.9%71.0M-3.7%73.8M+71.0%43.1M0.00
Operating income469M-15.0%551M+63.4%338M+26.2%268M-3.0%276M+91.3%
Interest expense18.1M+0.2%18.1M-3.6%18.8M+10.7%16.9M+125.2%7.53M-63.1%
Other non-operating income21.5M-9.6%23.8M+45.6%16.3M+1459.9%1.05M-5.1%1.10M-79.7%
Pre-tax income467M-16.2%557M+59.9%348M+39.9%249M+0.2%249M+92.2%
Income tax150M+32.7%113M+69.4%66.7M+42.6%46.8M+130.3%-154M-71156.2%
317M-28.6%444M+57.7%282M+39.3%202M-49.8%403M+212.0%
Net income to common317M-28.6%444M+57.7%282M+39.3%202M-49.8%403M+212.0%
$2.56-25.4%$3.43+63.3%$2.10+45.8%$1.44-47.4%$2.74+201.1%
EPS (basic)$2.64-24.6%$3.50+64.3%$2.13+43.9%$1.48-48.3%$2.86+201.1%
Weighted-avg shares (basic)120M-5.5%127M-3.9%132M-3.6%137M-2.7%141M+3.3%
Weighted-avg shares (diluted)124M-4.3%129M-3.6%134M-4.6%141M-4.2%147M+3.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
825M-24.0%1.09B+45.4%746M+1.0%739M-20.2%926M+67.0%
Cash & equivalents134M+15.5%116M-2.1%118M-49.5%234M+97.3%119M-19.6%
Accounts receivable426M+47.9%288M+23.6%233M+0.9%231M+154.0%91.0M-6.9%
Inventory176M+24.4%142M+11.2%128M+27.4%100M+85.7%53.9M-11.3%
Prepaid expenses64.6M+65.9%39.0M-19.9%48.6M+8.0%45.0M+11.2%40.5M+43.2%
2.53B+22.4%2.06B+19.1%1.73B-5.9%1.84B+66.7%1.10B+90.4%
Property, plant & equipment44.4M+8.8%40.9M+7.2%38.1M+8.6%35.1M+416.9%6.79M-35.9%
Operating lease right-of-use37.7M+10.3%34.2M-7.2%36.8M-9.0%40.5M+1920.4%2.00M-39.3%
Goodwill580M+39.2%417M+0.0%417M+1.9%409M0.00
Intangible assets981M+144.2%402M-15.0%473M-13.5%547M0.00
Deferred tax assets0.00-100.0%3.85M-12.1%4.39M-90.1%44.4M-71.4%155M
177M+27.3%139M+23.7%112M-14.0%131M+11.6%117M-72.2%
Accounts payable20.9M+103.9%10.2M-13.3%11.8M-33.2%17.7M+1048.2%1.54M-20.1%
Accrued liabilities156M+21.2%129M+28.0%101M+0.9%99.8M+308.2%24.4M+19.3%
Deferred revenue———3.25M+85.9%1.75M+0.0%
Short-term & current debt0.000.000.00-100.0%13.3M-85.1%89.4M-77.5%
2.48B+45.7%1.70B+3.0%1.65B-1.3%1.67B—
Long-term debt2.14B+42.3%1.51B+0.4%1.50B+0.4%1.49B+89.6%787M
Deferred revenue (non-current)———2.25M-10.9%2.53M-37.2%
Operating lease liability (total)34.6M+12.6%30.7M-4.6%32.2M-7.4%34.8M+1133.6%2.82M-42.1%
Deferred tax liabilities42.9M0.000.00—0.00
Other non-current liabilities114M+107.9%54.8M+45.2%37.7M+15.4%32.7M+5908.5%544K-84.3%
48.8M-86.6%364M+334.1%83.8M-50.6%170M-13.8%197M+30.4%
Preferred stock0.000.000.000.000.00
Common stock118K-4.1%123K-3.1%127K-5.9%135K-2.2%138K+2.2%
Additional paid-in capital12.0M0.00-100.0%2.41M-91.2%27.4M-89.3%256M-59.0%
Retained earnings54.8M-84.8%360M+297.4%90.5M-36.8%143M+343.1%-58.9M+87.6%
Accumulated other comprehensive income-18.1M-572.5%3.83M+141.3%-9.28M-906.3%-922K-48.7%-620K-2918.2%
Total equity incl. non-controlling48.8M-86.6%364M+334.1%83.8M-50.6%170M-13.8%197M+30.4%
Total liabilities & equity2.53B+22.4%2.06B+19.1%1.73B-5.9%1.84B+66.7%1.10B+90.4%
Common shares issued118M-4.3%123M-2.9%127M-6.2%135M-2.0%138M-2.2%
Common shares outstanding118M-4.3%123M-2.9%127M-6.2%135M-2.0%138M+2.1%
Shares outstanding (cover)118M-4.2%123M-2.9%127M-6.3%135M-1.7%138M+1.8%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
652M+36.0%479M+23.3%389M+61.8%240M-19.8%299M+440.0%
Depreciation & amortization88.1M+8.3%81.3M-4.2%84.9M+70.9%49.6M+1556.4%3.00M-8.7%
Intangible amortization76.7M+7.9%71.0M-3.7%73.8M+71.0%43.1M0.00
Share-based compensation51.6M+18.9%43.4M+18.5%36.6M+50.1%24.4M+17.2%20.8M+21.0%
Change in receivables128M+72.5%74.2M+2123.6%3.34M-96.0%83.9M+1342.6%-6.75M-117.6%
Change in inventory-2.55M-103.8%67.4M+150.6%26.9M+53.8%17.5M+337.2%-7.37M-123.5%
Other operating activities—0.000.00+100.0%-227K-7466.7%-3.00K+76.9%
-546M-107.8%-263M-171.1%-96.9M+80.1%-487M-19.9%-406M-618.5%
Capital expenditure6.97M-34.8%10.7M-30.1%15.3M+218.0%4.81M+230.1%1.46M-41.8%
Free cash flow645M+37.6%468M+25.5%373M+58.6%235M-21.0%298M+462.8%
Acquisitions726M0.000.00-100.0%999M0.00
Proceeds from sale of PP&E—0.000.00-100.0%26.0M0.00-100.0%
-85.2M+61.1%-219M+46.4%-408M-212.6%362M+365.4%77.9M+173.3%
Long-term debt issued0.000.000.000.00-100.0%785M
Long-term debt repaid0.000.000.000.000.00
Common stock repurchased342M+36.9%250M-37.9%402M+101.2%200M-42.9%350M+133.2%
Dividends paid0.000.000.000.000.00
Net change in cash20.6M+916.3%-2.52M+97.8%-116M-200.7%115M+498.4%-29.0M-205.3%
Interest paid11.4M+8.2%10.6M-7.4%11.4M+86.8%6.11M+85.3%3.30M-49.6%
Income taxes paid135M+67.0%80.6M+153.9%31.8M+95.7%16.2M+4426.4%-375K-308.3%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap7.93B+34.6%5.89B+20.6%4.88B-36.5%7.69B+38.8%5.54B-3.9%
P/E25.0×+88.7%13.3×-31.1%19.2×-47.2%36.4×+164.6%13.8×-69.2%
P/S5.7×-2.1%5.8×-7.3%6.3×-52.8%13.3×+5.9%12.5×-42.0%
P/B162.4×+903.5%16.2×-17.4%19.6×-75.3%79.3×+181.8%28.2×-26.3%
P/FCF12.3×-2.2%12.6×-9.0%13.8×-57.4%32.4×+74.1%18.6×-82.9%
Earnings yield4.0%-47.0%7.5%+45.0%5.2%+89.4%2.7%-62.2%7.3%+224.5%
FCF yield8.1%+2.2%8.0%+9.8%7.2%+134.6%3.1%-42.5%5.4%+485.4%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Helen I Torley$23.2M$39.7M$3.6M$157.57$124.75
FY2024Helen I Torley$12.7M$20.7M$4.2M$111.94$93.49
FY2023Helen I Torley$11.8M−$3.6M$3.6M$86.54$94.03
FY2022Helen I Torley$9.7M$22.8M$2.4M$133.22$89.90
FY2021Helen I Torley$7.5M$6M$2.4M$94.15$100.02
FY2020Helen I Torley$6.5M$24.4M$1.8M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: HALO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HALO filings on SEC EDGAR → Not investment advice.